NCT06596694 2026-06-01Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)Merck Sharp & Dohme LLCPhase 1/2 Recruiting180 enrolled